South Africa’s Alignd secures Knife Capital backing

Cape Town healthcare company Alignd has secured investment from Knife Capital to grow its maternity and kidney care programmes. The funding, provided through Knife Fund III, builds on the company’s work helping South African medical schemes fund care at home for patients nearing the end of life. The parties did not disclose the investment amount. Disrupt Africa

A funding gap in end-of-life care

Founded in 2018, Alignd began with a problem familiar to families facing the loss of a loved one. A medical scheme might cover a costly hospital stay while offering little support for a patient who wished to spend their final days at home. Alignd worked with schemes to fund home-based palliative care and built a network of more than 500 healthcare providers to deliver it. Free Press Releases Southern Africa

“South Africa’s private healthcare system largely pays for activity rather than outcomes, and patients and their families often carry the cost of that misalignment,” said Dr Lungi Nyathi, Alignd’s chief executive. Disrupt Africa

Alignd works with seven medical schemes, including GEMS, Fedhealth and Bonitas. The company says two-thirds of patients in its palliative care programme spent their final days at home or in hospice. It also credits the programme with saving medical schemes more than R600 million. Free Press Releases Southern Africa

What the investment means for patients

The Knife Capital funding will help Alignd expand two programmes it has already launched. Its maternity programme brings expectant parents, their healthcare providers and their medical scheme together to plan support around each family’s needs. In kidney care, Alignd coordinates the clinicians treating people with chronic kidney disease. The aim is to help patients preserve kidney function for as long as possible and continue receiving coordinated support if their kidneys fail. Disrupt Africa

For Knife Capital partner Catherine Young, the women-founded team’s record in palliative care helped make the investment case. Alignd’s next test is whether linking provider payments to patient outcomes can deliver similar gains for families navigating pregnancy and people living with long-term kidney disease.

Previous Story

Vodacom strengthens commitment to child online safety

Next Story

Apple names 45 finalists for its 2026 App Store Awards